These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31473027)

  • 41. Treatment Resistant Hypertension.
    Egan BM
    Ethn Dis; 2015 Nov; 25(4):495-8. PubMed ID: 26674466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistant hypertension: Renal denervation or intensified medical treatment?
    Morganti A; Mancia G
    Eur J Intern Med; 2018 Apr; 50():6-11. PubMed ID: 29287767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistant hypertension.
    Armario P; Oliveras A; de la Sierra A
    Rev Clin Esp (Barc); 2013 Nov; 213(8):388-93. PubMed ID: 23827205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistant hypertension in an aged woman presenting with clinical features simulating ectopic ACTH syndrome--response to spironolactone--.
    Harada E; Yasue H; Mizuno Y; Morikawa Y; Nakagawa H; Semba F; Yoshimura M; Saito Y
    Intern Med; 2010; 49(20):2235-9. PubMed ID: 20962442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients.
    Krum H; Nolly H; Workman D; He W; Roniker B; Krause S; Fakouhi K
    Hypertension; 2002 Aug; 40(2):117-23. PubMed ID: 12154100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].
    Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
    Nihon Jinzo Gakkai Shi; 2005; 47(1):38-45. PubMed ID: 15754762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms and treatment of resistant hypertension.
    Pimenta E; Gaddam KK; Oparil S
    J Clin Hypertens (Greenwich); 2008 Mar; 10(3):239-44. PubMed ID: 18326968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension.
    Abolghasmi R; Taziki O
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):75-8. PubMed ID: 21196617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-dose and very low-dose spironolactone in combination therapy for essential hypertension: evaluation by self-measurement of blood pressure at home.
    Hanazawa T; Obara T; Ogasawara K; Shinki T; Katada S; Inoue R; Metoki H; Asayama K; Kikuya M; Ohkubo T; Mano N; Imai Y
    Clin Exp Hypertens; 2011; 33(7):427-36. PubMed ID: 21777149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction.
    Rossignol P; Claggett BL; Liu J; Vardeny O; Pitt B; Zannad F; Solomon S
    Am J Hypertens; 2018 Mar; 31(4):407-414. PubMed ID: 29228101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistant hypertension: diagnosis and management.
    Papadopoulos DP; Papademetriou V
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):113-8. PubMed ID: 16891288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis and management of resistant hypertension.
    Schiffrin EL; Fisher NDL
    BMJ; 2024 Jun; 385():e079108. PubMed ID: 38897628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].
    Widimský J
    Vnitr Lek; 2015 Dec; 61(12):1067-71. PubMed ID: 26806502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Approaches for the Management of Resistant Hypertension in 2020.
    Aronow WS
    Curr Hypertens Rep; 2020 Jan; 22(1):3. PubMed ID: 31916065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study.
    Bobrie G; Frank M; Azizi M; Peyrard S; Boutouyrie P; Chatellier G; Laurent S; Menard J; Plouin PF
    J Hypertens; 2012 Aug; 30(8):1656-64. PubMed ID: 22728905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
    J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.